A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study (Q37206622)
Jump to navigation
Jump to search
scientific article published on 16 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study |
scientific article published on 16 May 2013 |
Statements
1 reference
A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study (English)
1 reference
Ulf Müller-Ladner
1 reference
Dae Hyun Yoo
1 reference
Pawel Hrycaj
1 reference
Pedro Miranda
1 reference
Edgar Ramiterre
1 reference
Mariusz Piotrowski
1 reference
Sergii Shevchuk
1 reference
Volodymyr Kovalenko
1 reference
Nenad Prodanovic
1 reference
Mauricio Abello-Banfi
1 reference
Sergio Gutierrez-Ureña
1 reference
Luis Morales-Olazabal
1 reference
Michael Tee
1 reference
Renato Jimenez
1 reference
Omid Zamani
1 reference
Sang Joon Lee
1 reference
HoUng Kim
1 reference
Won Park
1 reference
16 May 2013
1 reference
1 reference
1613-1620
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference